AMGEN 2042AMGEN 2042AMGEN 2042

AMGEN 2042

No trades
See on Supercharts

Key terms


Outstanding amount
‪415.42 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.65% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.66%
Maturity date
Jun 15, 2042
Term to maturity
17 years

About AMGEN 2042


Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
Jun 30, 2011
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.